Oragenics
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Oragenics
- Charles Pope, Interim Chief Executive Officer and Chairman of the ...
- Alan Dunton, Director
- Kimberly Murphy, Director
Popular executive movements at Oragenics
- James Kelly has joined the company as Chief Medical Officer (posted on March 19 2024).
- Charles Pope, who was Chairman of the Board, is promoted to Interim Chief Executive Officer and Chairman of the Board (posted on February 13 2024).
- John Gandolfo has joined the company as Director (posted on October 18 2023).
Click here to view some more movements at Oragenics
Create your alert
to follow the executive moves at Oragenics.
Biotechnology
Oragenics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Oragenics
- Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Files 10K and Provides Company Update :: Oragenics, Inc. (OGEN)
- Press Releases :: Oragenics, Inc. (OGEN)
- Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion :: Oragenics, Inc. (OGEN)
- Oragenics Announces Proposed Public Offering :: Oragenics, Inc. (OGEN)
- Oragenics Announces Pricing of Public Offering :: Oragenics, Inc. (OGEN)
- Oragenics Announces Closing of Public Offering :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Announces Leadership Transition :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion :: Oragenics, Inc. (OGEN)
- View more press releases Close
Social media about Oragenics
- Oragenics on Wikipedia, Google News & Yahoo Finance
- Oragenics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Charles Pope 
